Fred Hutch2h
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...
Fred Hutch1d
Skin in the game: Changing the story of Merkel cell carcinoma
Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...
Fred Hutch3d
The Beam: Updates from proton patients; new CT machine; alcohol and cancer; meet our new IT specialist
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
Fred Hutch2d
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...
Fred Hutch2d
Armin Rashidi, MD, PhD
Dr. Armin Rashidi studies how the microbiome, the community of bacteria living in and on our bodies, influences patients’ outcomes after intensive therapy for blood cancers. Our health is intimately ...